Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Immunome, Inc. (IMNM)

Pharmaceutical Preparations

https://www.immunome.com

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. It primarily operates in the U.S. Its current programs comprise Oncology (IMM-ONC-01), SARS-CoV-2 (IMM-BCP-01), and IMM20059 Anti-EPN1.

665 STOCKTON DRIVE, SUITE 300
EXTON, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/02/2020

Market Cap

830,552,352

Shares Outstanding

42,730,000

Weighted SO

45,028,433

Total Employees

N/A

Upcoming Earnings

08/14/2024

Beta

1.7880

Last Div

0.0000

Range

6.13-30.958

Chg

-0.1200

Avg Vol

927743

Mkt Cap

830552352

Exch

NASDAQ

Country

US

Phone

610 321 3700

DCF Diff

4.3853

DCF

9.3247

Div Yield

0.0000

P/S

77.0171

EV Multiple

-2.4704

P/FV

3.2656

Div Yield %

0.0000

P/E

-3.1567

PEG

0.0426

Payout

0.0000

Current Ratio

7.1249

Quick Ratio

7.1249

Cash Ratio

4.1437

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1892.6821

CCC

-1892.6821

Gross Margin

0.8740

Op Margin

-25.1849

Pretax Margin

-24.3502

Net Margin

-24.3502

Eff Tax Rate

-0.0008

ROA

-0.8865

ROE

-1.5786

ROCE

-1.0596

NI/EBT

1.0000

EBT/EBIT

0.9669

EBIT/Rev

-25.1849

Debt Ratio

0.0094

D/E

0.0109

LT Debt/Cap

0.0097

Total Debt/Cap

0.0108

Int Coverage

-1351.2139

CF/Debt

-21.8759

Equity Multi

1.1669

Rec Turnover

0.0000

Pay Turnover

0.1928

Inv Turnover

0.0000

FA Turnover

1.2512

Asset Turnover

0.0364

OCF/Share

-1.0117

FCF/Share

-1.0934

Cash/Share

4.6441

OCF/Sales

-5.6231

FCF/OCF

1.0807

CF Coverage

-21.8759

ST Coverage

-205.5593

CapEx Coverage

-12.3932

Div&CapEx Cov

-12.3932

P/BV

3.2656

P/B

3.2656

P/S

77.0171

P/E

-3.1567

P/FCF

-12.6738

P/OCF

-13.6696

P/CF

-13.6696

PEG

0.0426

P/S

77.0171

EV Multiple

-2.4704

P/FV

3.2656

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation